Immune responses following salivary gland administration of recombinant adeno-associated virus serotype 2 vectors

This publication has 27 references indexed in Scilit:

• Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics
  Proceedings of the National Academy of Sciences, 2004
• Local Adeno-Associated Virus-Mediated Interleukin 10 Gene Transfer Has Disease-Modifying Effects in a Murine Model of Sjögren's Syndrome
  Human Gene Therapy, 2003
• Immune responses to adeno-associated virus and its recombinant vectors
  Gene Therapy, 2003
• Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
  Gene Therapy, 2003
• Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins
  Journal of Clinical Investigation, 2002
• Recombinant Adeno-Associated Virus Serotype 2 Vectors Mediate Stable Interleukin 10 Secretion from Salivary Glands into the Bloodstream
  Human Gene Therapy, 2002
• Induction of Immunity to Antigens Expressed by Recombinant Adeno-Associated Virus Depends on the Route of Administration
  Clinical Immunology, 1999
• Repetitive Adenovirus Administration to the Parotid Gland: Role of Immunological Barriers and Induction of Oral Tolerance
  Human Gene Therapy, 1998
• Efficient and Stable Adeno-Associated Virus-Mediated Transduction in the Skeletal Muscle of Adult Immunocompetent Mice
  Human Gene Therapy, 1997
• Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.
  Molecular and Cellular Biology, 1987